Deka Bank Deutsche Girozentrale Iveric Bio, Inc. Transaction History

Deka Bank Deutsche Girozentrale

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 24, 2023	BUY	$18.67 - $24.56 $746,800 - $982,400	40,000 Added 100.0%	80,000 $1.88 Million
Q3 2022 Nov 02, 2022	SELL	$9.4 - $18.59 $711,580 - $1.41 Million	-75,700 Reduced 65.43%	40,000 $682,000
Q2 2022 Aug 03, 2022	BUY	$9.12 - $18.9 $346,559 - $718,200	38,000 Added 48.91%	115,700 $1.09 Million
Q1 2022 Apr 28, 2022	BUY	$12.15 - $16.83 $594,135 - $822,986	48,900 Added 169.79%	77,700 $1.27 Million
Q4 2021 Feb 02, 2022	BUY	$13.83 - $18.78 $11,064 - $15,024	800 Added 2.86%	28,800 $466,000
Q4 2020 Mar 12, 2021	BUY	$5.65 - $7.66 $158,200 - $214,480	28,000 New	28,000 $181,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.